Skip to main content

Table 2 Multi-drug resistance (MDR)a rates among MRSA from inpatients and outpatients by specimen sourceb

From: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

 

Inpatient

Outpatient

Specimen Source

Total N

(%) MDR

Total N

(%) MDR

Lower Respiratory Tract

5,134

(67.8)

1,136

(65.0)

Skin and Soft Tissue

2,122

(35.8)

2,275

(22.2)

Blood

3,064

(63.3)

904

(56.7)

  1. aMultiple-drug resistance (MDR): resistance to three or more of the following agents: ciprofloxacin, erythromycin, clindamycin, gentamicin, trimethoprim/sulfamethoxazole, linezolid, and vancomycin
  2. bCumulative data 1998 – March 2005